Medvolt AI is leveraging OpenAI-enabled intelligence to significantly accelerate the drug discovery process, aiming to reduce experimental cycles and identify promising molecules faster.
Why it matters
This article highlights a crucial application of AI in a high-impact sector: healthcare. By using OpenAI's capabilities to streamline drug discovery, Medvolt AI addresses a long-standing challenge of time, cost, and failure rates in pharmaceutical research. This advancement could lead to faster development of new treatments, potentially saving lives and improving global health outcomes by making life-saving drugs more accessible sooner.
A company called Medvolt AI is using smart AI tools from OpenAI to speed up how new medicines are found. This means they can test ideas faster and pick the best ones more quickly, which could lead to new drugs being available to people much sooner and at a lower cost.
Elon Musk's AI startup xAI has reportedly seen the departure of its last cofounder, Ross Nordeen, bringing the total number of cofounder exits to eleven.
Read on Economic Times Tech →Physical Intelligence is in talks to raise $1 billion at an $11 billion valuation, just four months after its previous funding round.
Read on Economic Times Tech →OpenSnow, a startup, uses government data and its own AI to provide superior snow forecasting for skiers, outperforming larger services.
Read on MIT Technology Review →